Both in Biotechnology
Bio-Techne vs Halozyme Therapeutics
Over the past year TECH returned +16.1% and HALO returned +100.8%; their daily moves had a correlation of 0.20.
TECH +16.1% HALO +100.8%Growth of $1, one year, split-adjusted
| Metric | TECH | HALO |
|---|---|---|
| Price | $72.66 | $130.91 |
| Market cap | $11.41B | $14.86B |
| Today | −0.07% | −0.21% |
| 1 month | +0.4% | +22.4% |
| 6 months | +32.1% | +104.7% |
| Year to date | +23.6% | +94.5% |
| 1 year | +17.2% | +100.6% |
| Revenue growth (YoY) | +1.3% | +47.7% |
| Gross margin | 65.8% | 83.5% |
| Net margin | 17.0% | 47.8% |
| P/E (TTM) | 62.7× | 35.9× |
| Price / sales | 9.4× | 8.9× |
| Net cash | $64.7M | -$1.92B |
| Dividend yield | 0.44% | — |
| Volatility (60d) | 2.5% | 45.9% |
| Short % of float | 4.9% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).